Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Dove Medical Press Ltd

ClinicalTrials.gov lists Dove Medical Press Ltd as lead sponsor of 11 trials. It has 10 active development programs.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 14 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 10 Sponsor delivery record Sponsor delivery record 1 Journals published in Journals published in 1 Latest dated events Latest dated events 11 Disease areas Disease areas 14 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 10 Sponsor delivery record Sponsor delivery record 1 Journals published in Journals published in 1 Latest dated events Latest dated events 11

Rows recorded per section

18 sections measured, none recorded

This page covers Dove Medical Press Ltd: 11 lead-sponsored trials and 0 legal-entity registrations.

Get the Dove Medical Press Ltd report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (14)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Periodontitis 3
Pruritus 3
Hemorrhage 2
Pain 2
Arthralgia 1

Showing 5 of 14 disease areas.

Start your 14-day trial Email me all 14 disease areas as a PDF

Trials by start year as sponsor or collaborator (2)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2023 10
2020 1

No forecast is made for this organization: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 11 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (10)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) Back Pain Not reported 1
HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) Hemorrhage Not reported 1
HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) Pain Not reported 1
HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) Periodontitis Not reported 1
HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089) Arthralgia Not reported 1

Showing 5 of 10 active programs.

Start your 14-day trial Email me all 10 active programs as a PDF

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
67% hit target (n=6) 0% on time (n=7)

Journals published in (1)

Journals published in
Journal Publications
Journal of inflammation research 1

Latest dated events (11)

Shown in this order: newest first.

Latest dated events
Date Event Source
2023-06-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-06-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-02-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-01-29 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-01-29 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 11 events.

Start your 14-day trial Email me all 11 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.